Point72 Asia Singapore Pte. Ltd. Makes New Investment in Ardent Health Partners, LLC (NYSE:ARDT)

Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,587 shares of the company’s stock, valued at approximately $27,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ARDT. US Bancorp DE acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $31,000. R Squared Ltd acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $37,000. New York State Common Retirement Fund acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $48,000. Deutsche Bank AG raised its holdings in Ardent Health Partners by 1,251.9% during the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock worth $49,000 after purchasing an additional 2,654 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Ardent Health Partners by 52.6% in the 4th quarter. Wells Fargo & Company MN now owns 8,704 shares of the company’s stock valued at $149,000 after acquiring an additional 3,002 shares during the period.

Ardent Health Partners Stock Performance

Shares of ARDT opened at $15.09 on Tuesday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The stock has a market capitalization of $2.16 billion and a P/E ratio of 9.26. The company’s fifty day moving average is $13.16 and its two-hundred day moving average is $14.79. Ardent Health Partners, LLC has a 1 year low of $11.31 and a 1 year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. On average, sell-side analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on ARDT. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Mizuho cut their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Thursday, May 15th. Stephens reaffirmed an “overweight” rating and issued a $22.00 target price on shares of Ardent Health Partners in a report on Tuesday, April 1st. Finally, Guggenheim lifted their target price on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $20.75.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.